Antineoplastic Combined Chemotherapy ProtocolsBlood Cell CountLeukocyte CountChemotherapy, AdjuvantAntineoplastic AgentsMotion SicknessErythrocyte CountCisplatinTreatment OutcomeCyclophosphamideDoxorubicinCombined Modality TherapyBreast NeoplasmsCell CountBlood CellsNeoplasmsPrognosisNauseaCD4 Lymphocyte CountLung NeoplasmsPlatelet CountSurvival AnalysisPaclitaxelDrug Resistance, NeoplasmDrug Administration ScheduleDisease-Free SurvivalVomitingTime FactorsNeoplasm StagingSurvival RateCarboplatinProspective StudiesLeukocytosisMedical OncologyErythrocytesRetrospective StudiesTaxoidsHematologic TestsColorectal NeoplasmsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsHematocritNeoplasm Recurrence, LocalFatigueNeoplasm MetastasisQuality of LifeDisease ProgressionHemoglobinsHIV InfectionsFluorouracilCell Line, TumorEtoposideLymphocyte CountFollow-Up StudiesNeoadjuvant TherapyLeukopeniaBiological MarkersLeukocytesMethotrexateRisk FactorsC-Reactive ProteinErythrocyte IndicesApoptosisCohort StudiesCytarabinePredictive Value of TestsPrecursor Cell Lymphoblastic Leukemia-LymphomaBone MarrowGranulocyte Colony-Stimulating FactorThrombocytopeniaQuestionnairesLeukemia, Myeloid, AcuteNeutropeniaViral LoadMultivariate AnalysisDose-Response Relationship, DrugVinblastineAcute DiseaseInduction ChemotherapyLeukemoid ReactionRecurrenceHematologyDaunorubicinAnti-HIV AgentsBleomycinAnemiaReticulocyte CountBlood SedimentationFeverCerebrospinal FluidSpinal PunctureNeutrophilsIfosfamideKaplan-Meier EstimateHematopoietic Stem Cell TransplantationDeoxycytidineAntimetabolites, AntineoplasticLeukemia, MyeloidHematopoiesisOrganoplatinum Compounds